Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Taki Chemical Co., Ltd. (4025.T)
Kakogawa, JP
Taki Chemical Co., Ltd., founded in 1885 and headquartered in Kakogawa, Japan, is a diversified company operating in the agriculture, chemical, and real estate sectors. Formerly known as Taki Fertilizer Manufacturing Co., Ltd. until its name change in 1974, the company provides a range of agricultural products including fertilizers and soil conditioners. Within its chemical division, Taki Chemical offers water treatment solutions like polyaluminum chloride, which is utilized for purifying drinking water, industrial water, urban sewage, and various civil and factory wastewaters, as well as for coagulation-sedimentation and organic sludge dewatering. Additionally, the company develops specialized functional chemical materials such as water-soluble aluminum salts (e.g., taxeram), aluminum phosphate binders, takibine, chixosil, high-purity metal oxides including tantalum and niobium pentaoxide, and advanced functional nanomaterials. The company also engages in real estate activities and serves a broad customer base across fields like agriculture, general chemistry, functional materials, and biotechnology.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +17.79% | +18.17% | +45.38% | +50.42% | +38.70% | +76.59% | +22.71% | -2.69% | +243.67% | +487.03% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+7.9% ★ Q1'26: +9.2% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+43.4% ★ Q1'26: +27.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+1.2% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+7.5% ★ Q1'26: +8.8% (vs Q1'25)
-
ROIC Chemicals: +3.4%+6.4% ★ Q1'26: +6.8% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-0.6% ★ Q1'26: -1.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.28× ★ Q1'26: 0.24× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Schwab International Small-Cap Equity ETF SCHC | 0.01% | 485.1K | 0.06% |
| 2 | Avantis International Small Cap Equity ETF AVDS | 0.01% | 26.7K | 0.30% |
| 3 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 868.7K | 0.06% |
| 4 | iShares Core TOPIX ETF 1475.T | 0.00% | 580.7K | 0.05% |
| 5 | Vanguard FTSE Pacific ETF VPL | 0.00% | 242.0K | 0.07% |
| 6 | Dimensional - International Small Cap ETF DFIS | 0.00% | 96.8K | 0.39% |
| 7 | Vanguard FTSE Developed Asia Pacific All Cap Index ETF VA.TO | 0.00% | 3.2K | 0.22% |
| 8 | Dimensional - International Small Cap Value ETF DISV | 0.00% | 55.8K | 0.42% |
| 9 | Amundi Japan TOPIX II UCITS ETF EUR Dist JPNU.L | 0.00% | 8.3K | 0.45% |
| 10 | Dimensional - International Core Equity Market ETF DFAI | 0.00% | 170.6K | 0.18% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akihito Ohya | Senior Executive Officer of Chemical Sales Department | — | — |
| Goro Suzuki | Senior Executive Officer & Director | — | male |
| Hiroyuki Izutsu | Senior Executive Officer & Director | — | male |
| Hisamori Kanaji | Senior Managing Executive Officer | — | male |
| Katsuhiko Taki | President & Representative Director | — | male |
| Kazunari Izumi | Senior Managing Executive Officer & Director | — | male |
| Shigeru Isoda | Associate Executive Officer | — | — |
| Shigeto Hashimoto | Associate Executive Officer | — | — |
| Tadashi Ohashi | Operating Officer | — | male |
| Takahisa Masaki | Senior Managing Executive Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4025.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
